Blood vessels grown in the lab in just five days could quickly prevent the tissue damage that can occur after an accident ...

ATLANTA & DALLAS, June 04, 2025--Chart Industries, Inc. (NYSE: GTLS) and Flowserve Corporation (NYSE: FLS) today announced that they have entered into a definitive agreement to combine in an all ...

Industrial companies Chart Industries Inc. and Flowserve Corp. agreed to merge in a deal valuing the combined company at about $19 billion.. Chart shareholders will receive 3.165 shares of ...

(Reuters) -U.S.-based equipment manufacturer Chart Industries and flow control systems maker Flowserve Corp agreed to merge in an all-stock deal, valuing the combined company at about $19 billion.

Chart Industries and Flowserve merge to create a $19B industrial-tech giant. Discover strategic synergies, industry scale, and financial insights.

Chart shareholders will own 53.5% of the combined company, while Flowserve shareholders would own 46.5%. Shares of Chart, based in Ball Ground, Ga., were recently down 1.6% at $159 in premarket ...

The fascial system builds a three-dimensional continuum of soft, collagen-containing, loose and dense fibrous connective tissue that permeates the body and enables all body systems to operate in an ...

Tissue Regenix Group Share Chat. Chat About TRX Shares - Stock Quote, Charts, Trade History, Share Chat, Financial Terms Glossary.

Chart had a market capitalization of $7.26 billion, as of stock’s last close, according to data compiled by LSEG, while Flowserve’s valuation stood at $6.6 billion.

Chart shareholders will receive 3.165 shares of Flowserve common stock for each share of Chart common stock owned, resulting in Chart shareholders owning approximately 53.5% and Flowserve ...